Medical therapies for inflammatory bowel disease
Hosp Pract (1995). 1998 May 15;33(5):141-4, 149-51, 156 passim.
doi: 10.1080/21548331.1998.11443696.
Affiliation
- 1 Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.
Abstract
Inflammatory bowel disease is a spectrum of disorders whose etiology and pathogenesis are unclear. No therapy is standard; many modalities exist for management. New drugs, improved formulations of existing drugs, combination therapy and biologic agents offer more effective relief and maintain disease remission.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Azathioprine / therapeutic use
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Inflammatory Bowel Diseases / drug therapy*
-
Inflammatory Bowel Diseases / etiology
-
Mesalamine / therapeutic use
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Mesalamine
-
Azathioprine